EA201992649A1 - BACTERIAL STRAIN COMPOSITIONS - Google Patents

BACTERIAL STRAIN COMPOSITIONS

Info

Publication number
EA201992649A1
EA201992649A1 EA201992649A EA201992649A EA201992649A1 EA 201992649 A1 EA201992649 A1 EA 201992649A1 EA 201992649 A EA201992649 A EA 201992649A EA 201992649 A EA201992649 A EA 201992649A EA 201992649 A1 EA201992649 A1 EA 201992649A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bacterial strain
strain compositions
compositions
diseases
treatment
Prior art date
Application number
EA201992649A
Other languages
Russian (ru)
Inventor
Имке Элизабет Малдер
Анна Этторре
Суад Ахмед
Партена Фотиаду
Саманта Юилл
Джозеф Роби Айринган Урсиа
Элен Савиньяк
Original Assignee
4Д Фарма Рисерч Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4Д Фарма Рисерч Лимитед filed Critical 4Д Фарма Рисерч Лимитед
Priority claimed from PCT/EP2018/065903 external-priority patent/WO2018229236A2/en
Publication of EA201992649A1 publication Critical patent/EA201992649A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Данное изобретение обеспечивает композиции, содержащие штаммы бактерий-комменсалов и органические кислоты, и их применение в лечении заболеваний.This invention provides compositions containing commensal strains and organic acids and their use in the treatment of diseases.

EA201992649A 2018-04-25 2018-06-14 BACTERIAL STRAIN COMPOSITIONS EA201992649A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1806780.1A GB201806780D0 (en) 2018-04-25 2018-04-25 Compositions comprising bacterial strains
PCT/EP2018/065903 WO2018229236A2 (en) 2017-06-14 2018-06-14 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
EA201992649A1 true EA201992649A1 (en) 2020-04-28

Family

ID=62236281

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201992648A EA037000B1 (en) 2018-04-25 2018-06-14 Compositions comprising a bacterial strain of the genus megasphera and uses thereof
EA201992649A EA201992649A1 (en) 2018-04-25 2018-06-14 BACTERIAL STRAIN COMPOSITIONS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201992648A EA037000B1 (en) 2018-04-25 2018-06-14 Compositions comprising a bacterial strain of the genus megasphera and uses thereof

Country Status (2)

Country Link
EA (2) EA037000B1 (en)
GB (1) GB201806780D0 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
WO2002080947A1 (en) * 2001-04-06 2002-10-17 Kyodoken Institute For Animal Science Research & Development Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions

Also Published As

Publication number Publication date
EA037000B1 (en) 2021-01-26
GB201806780D0 (en) 2018-06-06
EA201992648A1 (en) 2020-03-13

Similar Documents

Publication Publication Date Title
WO2018229236A3 (en) Compositions comprising bacterial strains
CY1122306T1 (en) COMPOSITIONS CONTAINING BAKTHPIAKA STRAIN
CY1124013T1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
CY1121473T1 (en) COMPOSITIONS INCLUDING BACTERIAL STRENGTHS
CY1122184T1 (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
CY1122148T1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
CY1122344T1 (en) BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN THE THERAPEUTIC TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
EA201891202A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201891199A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201891200A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
BR112017024384A2 (en) bacteria modified to reduce hyperphenylalaninemia
CY1125211T1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MD3768284T2 (en) Compositions of entrecoccus flagellin for use in therapy
PH12020551716A1 (en) Anti-ror antibody constructs
MX2020006191A (en) Therapeutic bacteriocins.
MX2020011027A (en) Trivalent trispecific antibody constructs.
MX2020001632A (en) Compositions comprising bacterial strains.
EA202092045A1 (en) TREATMENT AND PREVENTION OF PREECLAMPSIA
NZ751995A (en) Modified factor h binding protein
EA201992649A1 (en) BACTERIAL STRAIN COMPOSITIONS
CY1124851T1 (en) NEW UNIONS
EA202192101A1 (en) COMPOUNDS AND THEIR APPLICATIONS
EA202092204A1 (en) COMPOSITIONS
EA201992647A1 (en) BACTERIAL STRAIN COMPOSITIONS
EA202192418A1 (en) METHODS OF TREATMENT OF AL-AMYLOIDOSIS